Thomas Niel

Thomas Niel

InvestorPlace Contributor

Expertise: Micro-Cap Stocks, Shareholder Activist Stocks, Value Stocks

Education: Bachelors in Accounting, CFA Program Participant (Completed Level I in 2017)

About Thomas:
Thomas Niel is an investment writer at InvestorPlace. With a professional background in accounting and financial analysis, his understanding of both words and figures pays dividends when writing clear, concise stock analysis.

A value investor at heart, Thomas looks at the fundamentals. Peer analysis and earnings multiples rarely tell the whole story. But, Thomas believes valuation metrics are a great starting point to separate the wheat from the chaff.

His work has appeared at several websites, including Seeking Alpha and TipRanks. Outside of investment research, Thomas provides inbound marketing content to the investment management industry.

You can follow Thomas on Twitter and check out his track record on TipRanks.

Recent Articles

Novavax Has More Room to Run as the Vaccination Push Carries On

By Thomas Niel, InvestorPlace Contributor

With more overseas deals and its potential to still find success domestically in the booster-shot space, big upside remains for NVAX stock.

Tread Carefully With Ripple, Even as It Keeps Winning in Court

By Thomas Niel, InvestorPlace Contributor

After its big run-up, traders may opt to 'sell the news' with Ripple (XRP) once its legal battle with the SEC wraps up even if it prevails.

Wait for a Dip Before Buying Support.com Stock

By Thomas Niel, InvestorPlace Contributor

SPRT stock may be the strongest crypto mining play, but it's questionable whether it can hold onto its recent squeeze-induced gains

Skillz Stock Is Still Years Away From Its True Payoff Moment

By Thomas Niel, InvestorPlace Contributor

If company-specific stumbles, and/or a market correction, send SKLZ stock down to single digits? Consider it a more than opportune time to buy.

AMC Entertainment Stock Has Too Much Downside and Hardly Any Upside at All

By Thomas Niel, InvestorPlace Contributor

Bottom line: with more than 87% potential downside, and questionable room to run, stay away from AMC stock.

Load More